Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shantanu Banerji

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Hormones & Cancer|June 20, 2018
Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung CancerLaurel Grant, Shantanu Banerji, Leigh Murphy, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Life Years Gained and Healthcare Dollars Saved: National Economic Evidence Supporting Comprehensive Genomic Profiling as Standard of Care for Canadian Cancer PatientsStephanie Snow, Shantanu Banerji, Yvonne Bombard, et al.
Hormones & Cancer|February 4, 2012
Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancerSri Navaratnam, Georgios Skliris, Gefei Qing, et al.
International Journal of Population Data Science|May 19, 2021
Mapping three versions of the international classification of diseases to categories of chronic conditionsAmani F Hamad, Viktoriya Vasylkiv, Lin Yan, et al.
Cancer & Metabolism|October 12, 2022
Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controlsJulian O Kim, Robert Balshaw, Connel Trevena, et al.
Frontiers in Oncology|December 21, 2023
Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, CanadaDavid E Dawe, Rebekah Rittberg, Iqra Syed, et al.
BMC Public Health|April 10, 2022
Transitions between versions of the International Classification of Diseases and chronic disease prevalence estimates from administrative health data: a population-based studyRidwan A Sanusi, Lin Yan, Amani F Hamad, et al.
Frontiers in Oncology|October 5, 2023
Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort studyDavid E Dawe, Rebekah Rittberg, Iqra Syed, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian ArcticGlenwood D Goss, Johanna N Spaans, David Huntsman, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in CanadaBrandon S Sheffield, Shantanu Banerji, Allen Chankowsky, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Hormones & Cancer|June 20, 2018
Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung CancerLaurel Grant, Shantanu Banerji, Leigh Murphy, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Life Years Gained and Healthcare Dollars Saved: National Economic Evidence Supporting Comprehensive Genomic Profiling as Standard of Care for Canadian Cancer PatientsStephanie Snow, Shantanu Banerji, Yvonne Bombard, et al.
Hormones & Cancer|February 4, 2012
Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancerSri Navaratnam, Georgios Skliris, Gefei Qing, et al.
International Journal of Population Data Science|May 19, 2021
Mapping three versions of the international classification of diseases to categories of chronic conditionsAmani F Hamad, Viktoriya Vasylkiv, Lin Yan, et al.
Cancer & Metabolism|October 12, 2022
Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controlsJulian O Kim, Robert Balshaw, Connel Trevena, et al.
Frontiers in Oncology|December 21, 2023
Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, CanadaDavid E Dawe, Rebekah Rittberg, Iqra Syed, et al.
BMC Public Health|April 10, 2022
Transitions between versions of the International Classification of Diseases and chronic disease prevalence estimates from administrative health data: a population-based studyRidwan A Sanusi, Lin Yan, Amani F Hamad, et al.
Frontiers in Oncology|October 5, 2023
Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort studyDavid E Dawe, Rebekah Rittberg, Iqra Syed, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian ArcticGlenwood D Goss, Johanna N Spaans, David Huntsman, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in CanadaBrandon S Sheffield, Shantanu Banerji, Allen Chankowsky, et al.
Pageof 5